On Friday, Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) was 0.56% up from the session before settling in for the closing price of $62.01. A 52-week range for RYTM has been $35.17 – $68.58.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 189.02% over the past five years. When this article was written, the company’s average yearly earnings per share was at 37.85%. With a float of $58.22 million, this company’s outstanding shares have now reached $63.49 million.
Let’s look at the performance matrix of the company that is accounted for 283 employees. In terms of profitability, gross margin is 89.49%, operating margin of -126.13%, and the pretax margin is -123.16%.
Rhythm Pharmaceuticals Inc (RYTM) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Rhythm Pharmaceuticals Inc stocks. The insider ownership of Rhythm Pharmaceuticals Inc is 8.48%, while institutional ownership is 95.80%. The most recent insider transaction that took place on Apr 29 ’25, was worth 457,663. In this transaction Chief Human Resources Officer of this company sold 7,031 shares at a rate of $65.09, taking the stock ownership to the 19,209 shares. Before that another transaction happened on Apr 29 ’25, when Company’s EVP, Head of International sold 6,745 for $65.08, making the entire transaction worth $438,946. This insider now owns 37,655 shares in total.
Rhythm Pharmaceuticals Inc (RYTM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 37.85% per share during the next fiscal year.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Trading Performance Indicators
You can see what Rhythm Pharmaceuticals Inc (RYTM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 28.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.82, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -1.42 in one year’s time.
Technical Analysis of Rhythm Pharmaceuticals Inc (RYTM)
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) saw its 5-day average volume 0.49 million, a negative change from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 75.63%. Additionally, its Average True Range was 2.79.
During the past 100 days, Rhythm Pharmaceuticals Inc’s (RYTM) raw stochastic average was set at 81.53%, which indicates a significant increase from 68.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.93% in the past 14 days, which was higher than the 51.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $58.35, while its 200-day Moving Average is $54.92. Nevertheless, the first resistance level for the watch stands at $62.81 in the near term. At $63.25, the stock is likely to face the second major resistance level. The third major resistance level sits at $64.07. If the price goes on to break the first support level at $61.55, it is likely to go to the next support level at $60.73. Assuming the price breaks the second support level, the third support level stands at $60.29.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Key Stats
There are 63,621K outstanding shares of the company, which has a market capitalization of 3.97 billion. As of now, sales total 130,130 K while income totals -260,600 K. Its latest quarter income was 32,700 K while its last quarter net income were -49,500 K.
